Protalix BioTherapeutics (PBDA.F) Q1 2025 Earnings

17MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.06
-0.01
0.04
0.09

Details

Expected EPS
0.06410320000000001
Actual EPS
0.091576
Surprise EPS
0.03
Surprise Percent
+42.86%

Description

Protalix BioTherapeutics (PBDA.F) has reported earnings of 0.091576 per share for Q1 2025.

0 Comments

Share your thoughts